Symptomatic Hypertrophic Cardiomyopathy (HCM) research hub

Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM

This study looks at how safe a medicine called aficamten is over a long time for adults with a heart condition called hypertrophic cardiomyopathy (HCM). It's for people who have already tried aficamten in a previous study and want to continue their treatment.